Hines, Illinois 60141

  • Parkinson's Disease


Parkinson's disease (PD) is a neurodegenerative disorder characterized by muscle rigidity, tremor, a slowing of physical movement (bradykinesia) and, in extreme cases, a loss of physical movement. The primary symptoms are the results of decreased stimulation of the motor cortex arising from the basal ganglia normally caused by the insufficient formation and action of dopamine, which is produced in the dopaminergic neurons of the brain. Secondary symptoms may include high level cognitive dysfunction and subtle language problems. Included in the symptomatology experienced by patients with PD, visual abnormalities are not uncommon. Visual changes among patients with PD appear not only dynamic in nature, but differentially affected based on the course of the disease and, perhaps more importantly, its treatment. Parkinson's disease has significant ramifications not only in observation of irregularities in vision, but how vision interacts with entrainment of the circadian clock. The purpose of this study is to examine the relationship between PD and operation of a unique set of retinal cells known to regulate the circadian clock and sleep-wake cycles in human subjects.


Inclusion Criteria: age 18-64 best corrected visual acuity of 20/25 or better in each eye - Exclusion Criteria: evidence of any form of eye disease, inability to understand and sign informed consent. -



Primary Contact:

Bruce Ira Gaynes, OD, PharmD
Phone: 708-216-6262
Email: Bruce.Gaynes@va.gov

Backup Contact:

Email: Jasvinder.Chawla@va.gov
Jasvinder Chawla, MD
Phone: 708-202-3800

Location Contact:

Hines, Illinois 60141
United States

Bruce Ira Gaynes, OD, PharmD
Phone: 708-216-6262
Email: Bruce.Gaynes@va.gov

Site Status: Recruiting

Data Source: ClinicalTrials.gov

Date Processed: September 26, 2021

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.